The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis-Reference-Cited by-同舟云学术

The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis

Published:2015-09-14 Issue:8 Volume:75 Page:1567-1573
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Brkic Zana,van Bon Lenny,Cossu Marta,van Helden-Meeuwsen Cornelia G,Vonk Madelon C,Knaapen Hanneke,van den Berg Wim,Dalm Virgil A,Van Daele Paul L,Severino Adriana,Maria Naomi I,Guillen Samara,Dik Willem A,Beretta Lorenzo,Versnel Marjan A,Radstake Timothy

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference33 articles.

1. Scleroderma;Gabrielli;N Engl J Med,2009

2. Criteria for the classification of early systemic sclerosis;LeRoy;J Rheumatol,2001

3. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis;Koenig;Arthritis Rheum,2008

4. Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis;Vigone;Rheumatology (Oxford),2015

5. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative;van den Hoogen;Ann Rheum Dis,2013

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment;Reports;2024-08-02

2. Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis;International Journal of Molecular Sciences;2024-07-20

3. Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?;La Revue de Médecine Interne;2024-07

4. Role of Macrophages in Promoting Inflammation and Fibrosis in Systemic Sclerosis;Macrophages - Molecular Pathways and Immunometabolic Processes [Working Title];2024-06-04

5. Immunogenetics of Systemic Sclerosis;Genes;2024-05-05